118 related articles for article (PubMed ID: 24582318)
1. TLR9 expressed on plasma membrane acts as a negative regulator of human B cell response.
Guerrier T; Pochard P; Lahiri A; Youinou P; Pers JO; Jamin C
J Autoimmun; 2014 Jun; 51():23-9. PubMed ID: 24582318
[TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor 9 activation induces expression of membrane-bound B-cell activating factor (BAFF) on human B cells and leads to increased proliferation in response to both soluble and membrane-bound BAFF.
Abu-Rish EY; Amrani Y; Browning MJ
Rheumatology (Oxford); 2013 Jul; 52(7):1190-201. PubMed ID: 23436580
[TBL] [Abstract][Full Text] [Related]
3. Could DNA-reactive B lymphocytes be activated through HIV-1 DNA-stimulation involving BCR/TLR-9 pathway to yield antibodies targeting viral DNA?
Norelli S
Med Hypotheses; 2014 Dec; 83(6):659-63. PubMed ID: 25441838
[TBL] [Abstract][Full Text] [Related]
4. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
[TBL] [Abstract][Full Text] [Related]
5. Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens.
Andersen JM; Al-Khairy D; Ingalls RR
Biol Reprod; 2006 May; 74(5):824-31. PubMed ID: 16421230
[TBL] [Abstract][Full Text] [Related]
6. TGFβ activated kinase 1 (TAK1) at the crossroad of B cell receptor and Toll-like receptor 9 signaling pathways in human B cells.
Szili D; Bankó Z; Tóth EA; Nagy G; Rojkovich B; Gáti T; Simon M; Hérincs Z; Sármay G
PLoS One; 2014; 9(5):e96381. PubMed ID: 24801688
[TBL] [Abstract][Full Text] [Related]
7. CD19 controls Toll-like receptor 9 responses in human B cells.
Morbach H; Schickel JN; Cunningham-Rundles C; Conley ME; Reisli I; Franco JL; Meffre E
J Allergy Clin Immunol; 2016 Mar; 137(3):889-98.e6. PubMed ID: 26478008
[TBL] [Abstract][Full Text] [Related]
8. T-bet is a new synergistic meeting point for the BCR and TLR9 signaling cascades.
Kövesdi D; Angyal A; Huber K; Szili D; Sármay G
Eur J Immunol; 2014 Mar; 44(3):887-93. PubMed ID: 24249581
[TBL] [Abstract][Full Text] [Related]
9. Syk is indispensable for CpG-induced activation and differentiation of human B cells.
Kremlitzka M; Mácsik-Valent B; Erdei A
Cell Mol Life Sci; 2015 Jun; 72(11):2223-36. PubMed ID: 25543269
[TBL] [Abstract][Full Text] [Related]
10. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
Merlo A; Calcaterra C; Mènard S; Balsari A
J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
[TBL] [Abstract][Full Text] [Related]
11. The expression and function of Toll-like receptors 3 and 9 in human colon carcinoma.
Nojiri K; Sugimoto K; Shiraki K; Tameda M; Inagaki Y; Kusagawa S; Ogura S; Tanaka J; Yoneda M; Yamamoto N; Okano H; Takei Y; Ito M; Kasai C; Inoue H; Takase K
Oncol Rep; 2013 May; 29(5):1737-43. PubMed ID: 23467704
[TBL] [Abstract][Full Text] [Related]
12. Higher-order CpG-DNA stimulation reveals distinct activation requirements for marginal zone and follicular B cells in lupus mice.
Brummel R; Roberts TL; Stacey KJ; Lenert P
Eur J Immunol; 2006 Jul; 36(7):1951-62. PubMed ID: 16791898
[TBL] [Abstract][Full Text] [Related]
13. Signaling in B cells via Toll-like receptors.
Peng SL
Curr Opin Immunol; 2005 Jun; 17(3):230-6. PubMed ID: 15886111
[TBL] [Abstract][Full Text] [Related]
14. TLR9 signaling failure renders Peyer's patch regulatory B cells unresponsive to stimulation with CpG oligodeoxynucleotides.
Booth JS; Arsenault R; Napper S; Griebel PJ; Potter AA; Babiuk LA; Mutwiri GK
J Innate Immun; 2010; 2(5):483-94. PubMed ID: 20551621
[TBL] [Abstract][Full Text] [Related]
15. The human Burkitt lymphoma cell line Namalwa represents a homogenous cell system characterized by high levels of Toll-like receptor 9 and activation by CpG oligonucleotides.
Henault M; Lee LN; Evans GF; Zuckerman SH
J Immunol Methods; 2005 May; 300(1-2):93-9. PubMed ID: 15894327
[TBL] [Abstract][Full Text] [Related]
16. Functional cell surface expression of toll-like receptor 9 promotes cell proliferation and survival in human hepatocellular carcinomas.
Tanaka J; Sugimoto K; Shiraki K; Tameda M; Kusagawa S; Nojiri K; Beppu T; Yoneda K; Yamamoto N; Uchida K; Kojima T; Takei Y
Int J Oncol; 2010 Oct; 37(4):805-14. PubMed ID: 20811701
[TBL] [Abstract][Full Text] [Related]
17. Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
Pedersen G; Andresen L; Matthiessen MW; Rask-Madsen J; Brynskov J
Clin Exp Immunol; 2005 Aug; 141(2):298-306. PubMed ID: 15996194
[TBL] [Abstract][Full Text] [Related]
18. B-cell receptor for antigen modulates B-cell responses to complex TLR9 agonists and antagonists: implications for systemic lupus erythematosus.
Goeken JA; Layer T; Fleenor S; Laccheo M; Lenert P
Lupus; 2010 Oct; 19(11):1290-301. PubMed ID: 20605877
[TBL] [Abstract][Full Text] [Related]
19. Co-activation through TLR4 and TLR9 but not TLR2 skews Treg-mediated modulation of Igs and induces IL-17 secretion in Treg: B cell co-cultures.
Adjobimey T; Satoguina J; Oldenburg J; Hoerauf A; Layland LE
Innate Immun; 2014 Jan; 20(1):12-23. PubMed ID: 23529856
[TBL] [Abstract][Full Text] [Related]
20. Chicken TLR21 is an innate CpG DNA receptor distinct from mammalian TLR9.
Keestra AM; de Zoete MR; Bouwman LI; van Putten JP
J Immunol; 2010 Jul; 185(1):460-7. PubMed ID: 20498358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
